- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Our comprehensive surgical team at Children's Hospital Colorado offers the most innovative care for every surgical intervention, thanks to rigorous research initiatives designed to explore diagnostic and treatment approaches that will deliver the best possible outcomes for kids. Because our team is diverse — from a range of surgical specialties, to board-certified pediatric anesthesiologists, to respiratory therapists, child life specialists, pediatric nurses and more — our research efforts are, too.
Fetuses have unique properties that allow them to heal without scars. A fetal surgeon at Children's Colorado is applying those properties to help heal diabetic wounds.
Researchers at Children’s Hospital Colorado are investigating the safety and feasibility of providing regenerative therapy for a rare congenital heart defect called hypoplastic left heart syndrome (HLHS).
Our current projects explore gene therapy, wound healing physiology, the diagnostic and treatment possibilities of big data and many more.
"The Center for Children's Surgery is committed to the continuous improvement of the surgical care of children through innovation and research. We have NIH-funded surgeon scientists researching all aspects of care, from the laboratory bench to the bedside."
Duncan Wilcox, MD
Surgeon in ChiefLearn about Dr. Wilcox's research
We strive to develop and utilize treatment methods that minimize invasiveness and maximize benefit, continually pushing for better, more effective care. These advances not only help patients heal, they save lives.
Some areas of research within the Center for Children's Surgery include:
Learn more about the Center for Children's Surgery
Despite the current therapies for chronic wounds in diabetic patients, a significant number of wounds fail to heal. In this study, our researchers targeted two key aspects of non-healing diabetic wounds – chronic inflammation and high oxidative stress – by applying cerium oxide nanoparticles (CNP) as a novel therapeutic agent. Our data showed that local treatment of the diabetic wound with CNP-miR146a resulted in improved healing of diabetic wounds without impairing the biomechanical properties of the skin post-healing. This demonstrates that CNP-miR146a therapy has potentially far-reaching implications for diabetic wound healing research.